| Authors: |
Roe EF; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Votaw NL; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Lazar KM; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Burke KN; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA., Miranda HA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA., Fries CN; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Rock ML; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Macintyre AN; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA; Department of Medicine, Duke University, Durham, NC, USA., Stover EL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Huskey JB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Harris SJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Landon CD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Heaton NS; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Collier JH; Department of Biomedical Engineering, Duke University, Durham, NC, USA. Electronic address: joel.collier@duke.edu. |
